Susquehanna Portfolio Strategies’s Beam Therapeutics BEAM Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.19M	Buy	151,216 +13,084	+9%	+$395K	0.08%	275
2026 Q1	$3.29M	Hold	138,132	–	–	0.05%	388
2025 Q4	$3.83M	Hold	138,132	–	–	0.06%	354
2025 Q3	$3.35M	Buy	138,132 +14,641	+12%	+$291K	0.05%	388
2025 Q2	$2.1M	Buy	+123,491	New	+$2.15M	0.05%	364
2024 Q4	–	Sell	-126,710	Closed	-$3.1M	–	53
2024 Q3	$3.1M	Sell	126,710 -17,844	-12%	-$461K	0.21%	105
2024 Q2	$3.39M	Hold	144,554	–	–	0.14%	155
2024 Q1	$4.78M	Hold	144,554	–	–	0.11%	221
2023 Q4	$3.93M	Buy	+144,554	New	+$3.59M	0.07%	319

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Susquehanna Portfolio Strategies's BEAM Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Beam Therapeutics (BEAM) stake by 9.5% in Q2 2026, buying an estimated $395K and bringing the position to 151,216 shares worth $5.19M. The position accounts for 0.08% of the portfolio, ranked #275.

Susquehanna Portfolio Strategies first reported a position in BEAM in Q4 2023 and has held it in 9 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Susquehanna Portfolio Strategies held 151,216 shares of Beam Therapeutics worth $5.19M as of Q2 2026.
Susquehanna Portfolio Strategies bought 13,084 Beam Therapeutics shares in Q2 2026, an estimated $395K.
Beam Therapeutics made up 0.08% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #275 holding.
Susquehanna Portfolio Strategies first reported a position in Beam Therapeutics in Q4 2023 and has held it in 9 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.